A1BG-AS1

Across TCGA pan-cancer cohorts, A1BG-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated A1BG-AS1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher A1BG-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated A1BG-AS1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and UVM show a favorable association.

LUAD, KIRP, and KIRC are the cancer types where A1BG-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	III,IV	0.604	0.370	.005	69	view →
KIRP	DFS	Tertile	All	0.515	0.726	.007	56	view →
KIRC	DFS	Median	IV	0.213	0.447	.001	36	view →
LUSC	DFS	Tertile	III,IV	0.423	0.739	.001	30	view →
UVM	OS	Tertile	All	0.816	0.448	.001	29	view →
LGG	OS	Quartile	All	0.361	0.563	<.001	27	view →
BRCA	OS	Median	All	0.976	0.948	.009	24	view →
THYM	OS	Median	All	1.000	0.752	.002	21	view →
LIHC	OS	Tertile	All	0.781	0.634	.007	20	view →
PAAD	DFS	Tertile	All	0.494	0.251	.005	19	view →
ESCA	DFS	Tertile	II,III,IV	0.550	0.370	.020	17	view →
SKCM	DFS	Quartile	III,IV	0.186	0.520	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

A1BG-AS1–LUAD (DFS)

Open the LUAD breakdown →